ARTICLE | Company News
Keryx board of directors update
February 12, 2001 8:00 AM UTC
Keryx Biopharmaceuticals Inc. (LSE:KRX; KERX), Jerusalem, Israel Business: Metabolic, Cancer Appointed: J. Wilson Totten, group R&D director at Shire Pharmaceuticals plc; and Malcolm Hoenlein, executi...